Dec 16, 2021 8:00 am EST Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia
Nov 10, 2021 4:10 pm EST VolitionRx Limited Announces Third Quarter 2021 Financial Results and Business Update
Nov 8, 2021 8:30 am EST VolitionRx Limited Schedules Third Quarter 2021 Earnings Conference Call and Business Update
Nov 4, 2021 8:33 am EDT Volition Veterinary Presents Two Posters at the 2021 Veterinary Cancer Society Conference
Aug 11, 2021 4:10 pm EDT VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update
Aug 4, 2021 8:15 am EDT VolitionRx Limited Schedules Second Quarter 2021 Earnings Conference Call and Business Update
Jul 22, 2021 8:00 am EDT Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring
May 11, 2021 4:10 pm EDT VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update
May 6, 2021 8:15 am EDT VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and Business Update
Mar 31, 2021 8:30 am EDT VolitionRx Limited Announces Publication of Significant Nu.Q® Capture Mass Spectrometry Paper
